Subject matters | Details | Categories |
---|---|---|
Health, Intellectual Property, Science and Technology
|
Consultations on Canada's taxation policies relating to scientific research and experimental development tax credits as they apply to innovative pharmaceutical companies
|
Policies or Program
|
Health, Intellectual Property, Science and Technology
|
Consultations on proposed changes to the Patented Medicine Prices Review Board (PMPRB)'s framework, guidelines and regulations
|
Policies or Program, Regulation
|
Health, Intellectual Property, Science and Technology
|
Implementation of Amendments to Canada's Food and Drugs Act and Regulations as they relate to the licencing and post-market surveillance of pharmaceuticals, consumer health products and natural health products
|
Legislative Proposal, Bill or Resolution, Regulation
|
Intellectual Property, Science and Technology
|
Implementation of the Canada-European Union Free Trade Agreement with respect to provisions relating to intellectual property protection.
|
Policies or Program
|
Bayer Inc. ("Bayer") is a Canadian subsidiary of Bayer AG, an international research-based group with core businesses in health care, crop science, and innovative materials.Headquartered in Toronto, Ontario, Bayer Inc. operates the Bayer Group's HealthCare and MaterialScience businesses in Canada. Bayer CropScience Inc., headquartered in Calgary, Alberta operates as a separate legal entity in Canada. Together, the companies play a vital role in improving the quality of life for Canadians - producing products that fight diseases, protecting crops and animals, and developing high-performance materials for applications in numerous areas of daily life.
Viktoria Friedrich, Country President and General Manager - Pharmaceutical Division
Address:
2920 Matheson Blvd. East
Mississauga, ON L4W 5R6
Canada
Telephone number:
905-282-5521
Bayer Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking